The Arora Report

Rss Facebook Twitter Linkedin

March 23, 2017

SIGNAL: MICRON TECHNOLOGY ROCKETING AFTER EARNINGS, TAKE ADVANTAGE OF STRENGTH TO BOOK PARTIAL PROFITS $MU

SIGNAL: MICRON TECHNOLOGY ROCKETING AFTER EARNINGS, TAKE ADVANTAGE OF STRENGTH TO BOOK PARTIAL PROFITS $MU

This post was just published on ZYX Buy Change Alert. 

MU is long from $21.77.  As of this writing it is trading at $29.37.  25% of the full core position size is being held.  Partial profits have previously been taken.

This computer memory manufacturer reported earnings better than the consensus and better than the whisper numbers. This is the reason the stock is up  $3.30 in the after market.  The stock is very actively trading.

What To Do Now

Those in the stock may consider taking partial profits on  another 10% tranche in the zone of $29 to $30.34, consider holding the remaining 15%. 

… Please click here or the title below to read more.
Read More
March 23, 2017

A SPECIAL NOTE FOR NEW SUBSCRIBERS, LONG-TERM INVESTMENTS AND/OR SHORT-TERM TRADES, AN IMPORTANT TIP $FLXN $XBI $IBB $LABU $LABD $SPY

A SPECIAL NOTE FOR NEW SUBSCRIBERS, LONG-TERM INVESTMENTS AND/OR SHORT-TERM TRADES, AN IMPORTANT TIP $FLXN $XBI $IBB $LABU $LABD $SPY

This post was just published on ZYX Buy Change Alert. 

Our subscribers have a wide range of interests. Some focus only on long-term investments, others focus only on short-term trades.  Some do both.

If your focus is on long-term investments, there is no need to be nimble.  There is no need to be watching your computer screen.  We typically give buy zones ahead of time.  Usually there is plenty of time to act at your convenience.

If you are a long-term investor, you can simply ignore emails related to short-term trades and emails titled INTELLIGENCE.  Please read tip number 10 under Important Tips in Getting A Running Start Guide.

… Please click here or the title below to read more.
Read More
March 23, 2017

PLAN ON FLEXION THERAPEUTICS, QUICK DENIAL MAY MEAN HIGHER POTENTIAL OF A BUYOUT $FLXN $SNY

This post was just published on ZYX Buy Change Alert.

A quick denial of a potential deal is not typical, as has happened in the case of FLXN.  One hypothetical explanation is that  the deal is potentially in the works but a quick run-up in the stock makes the deal difficult.  Hypothetically, this could be the reason for a quick denial.

Fortunately we were able to be nimble. Subscribers who were able to be nimble made some profits.  Subscribers who were not able to be nimble, did not lose any money.

The Plan

If the historical pattern holds, the stock is likely to drift down. 

… Please click here or the title below to read more.
Read More
March 23, 2017

FLEXION THERAPEUTICS: CHANGING THE BUY ZONE TO $20 TO $21.15, SNY DENIES THE DEAL $FLXN $SYN

This post was just published on ZYX Buy Change Alert.

More later

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.… Please click here or the title below to read more.

Read More
March 23, 2017

UPDATE ON FLEXION THERAPEUTICS $FLXN $SYN

This post was just published on ZYX Buy Change Alert.

The stock has surged to over $26 as of this writing. Consider not chasing the price.  If you do not have a fill, we are raising the top end of the buy zone to $24.31 and the preferred point is being raised to $23.36.

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.… Please click here or the title below to read more.

Read More
March 23, 2017

INTELLIGENCE: A NEW IDEA ON FLEXION THERAPEUTICS, RUMORS OF A BUYOUT $FLXN $SNY

This post was just published on ZYX Buy Change Alert.

For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide intelligence on trades that we do not recommend, but our subscribers may be able to take advantage.

FLXN is a biopharma. There are reports of a potential buyout buy SNY.  The stock is jumping as we are writing.  This is suitable only for super aggressive investors as the risk of loss is very high. 

… Please click here or the title below to read more.
Read More
March 23, 2017

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy